Skip to content
PeptideFactSheets

Status database

A single scan of status, evidence, and entity type.

This linkable reference asset pulls from the typed fact-sheet library so each row points back to a full source-backed page.

Status coverage

FDA approved for specific uses18
In clinical trials10
Preclinical research2
Not FDA approved16
Discontinued2

Evidence coverage

Strong human evidence for approved uses17
Moderate human evidence8
Early human evidence11
Mostly animal or lab research7
Limited or unclear evidence5

Alpha-ketoglutarate

A central metabolic intermediate with mouse healthspan findings and unfinished human geroscience questions.

Healthy agingMetabolic healthMitochondrial health
Related molecule
In clinical trialsMostly animal or lab researchOpen

BPC-157

An experimental synthetic peptide popular online despite very limited reliable human evidence.

recoveryexperimental
Peptide
Not FDA approvedMostly animal or lab researchOpen

Bremelanotide

A melanocortin-receptor peptide approved for a narrowly defined sexual-desire disorder.

sexual healthmelanocortinapproved medicine
Peptide
FDA approved for specific usesStrong human evidence for approved usesOpen

Cagrilintide

An investigational long-acting amylin analog studied alone and with semaglutide for obesity and type 2 diabetes.

amylin analogweight researchmetabolic research
Peptide
In clinical trialsModerate human evidenceOpen

CJC-1295

An unapproved growth hormone-releasing hormone analog with limited human data.

growth hormone pathwayexperimental
Peptide
Not FDA approvedEarly human evidenceOpen

Creatine

A well-studied performance supplement with credible muscle evidence and a less certain cognitive-aging frontier.

Muscle and performanceCognition and brainHealthy aging
Related molecule
Not FDA approvedModerate human evidenceOpen

Dasatinib plus quercetin

An experimental senolytic pairing that combines a serious cancer medicine with a flavonoid.

Healthy agingCellular senescenceLung research
Related molecule
In clinical trialsEarly human evidenceOpen

Elamipretide

A mitochondria-targeting peptide with an accelerated FDA approval for a narrow Barth syndrome indication.

mitochondrial researchrare diseasemuscle function
Peptide
FDA approved for specific usesModerate human evidenceOpen

Exenatide

An FDA-approved diabetes peptide whose promising Phase 2 Parkinson signal failed in a larger Phase 3 trial.

GLP-1 receptor agonistdiabetesParkinson research
Peptide
FDA approved for specific usesStrong human evidence for approved usesOpen

Fisetin

A plant flavonoid with striking mouse senolytic findings but no proven human longevity or frailty benefit.

Healthy agingCellular senescenceHeart and vascular
Related molecule
In clinical trialsMostly animal or lab researchOpen

GHK-Cu

A copper-binding tripeptide used in cosmetic research, with mostly laboratory and animal wound-healing evidence.

skin researchwound researchhair research
Peptide
Not FDA approvedMostly animal or lab researchOpen

GHRP-2

An unapproved ghrelin-receptor agonist that raises growth hormone and appetite without proven muscle-building outcomes.

growth hormone pathwaymuscle claimsappetite research
Peptide
Not FDA approvedEarly human evidenceOpen

Humanin

A mitochondrial-derived peptide studied for cell survival, neuroprotection, metabolism, and aging mostly in preclinical work.

mitochondrial researchcognitive researchaging biology
Peptide
Preclinical researchMostly animal or lab researchOpen

Ipamorelin

An unapproved growth hormone secretagogue with limited clinical evidence and FDA-identified concerns.

growth hormone pathwayexperimental
Peptide
Not FDA approvedEarly human evidenceOpen

Ketone esters and beta-hydroxybutyrate

Compounds that raise circulating ketones reliably but have not established cognitive or healthy-aging benefit.

Cognition and brainHealthy agingMetabolic health
Related molecule
In clinical trialsEarly human evidenceOpen

Kisspeptin

A reproductive signaling peptide studied in fertility, hormone release, and brain responses.

reproductive healthfertility researchneuroendocrine research
Peptide
In clinical trialsEarly human evidenceOpen

Linaclotide

A minimally absorbed peptide medicine approved for several constipation disorders in defined adult and pediatric populations.

digestive healthconstipationIBS
Peptide
FDA approved for specific usesStrong human evidence for approved usesOpen

Liraglutide

An established GLP-1 medicine approved for specific diabetes and weight-management uses.

GLP-1metabolic healthapproved medicine
Peptide
FDA approved for specific usesStrong human evidence for approved usesOpen

Lixisenatide

A discontinued U.S. GLP-1 product with established diabetes evidence and an encouraging but unconfirmed Parkinson trial.

GLP-1 receptor agonistdiabetesParkinson research
Peptide
DiscontinuedModerate human evidenceOpen

Metformin

A foundational diabetes medicine being studied in geroscience, without an approved anti-aging use.

Metabolic healthHealthy agingMuscle and performance
Related molecule
FDA approved for specific usesStrong human evidence for approved usesOpen

MOTS-c

A mitochondrial-derived peptide with intriguing metabolic and exercise biology but no proven human therapy.

mitochondrial researchmetabolic researchexercise biology
Peptide
Preclinical researchMostly animal or lab researchOpen

NAD+

A central cellular coenzyme with legitimate biology but little clinical-outcomes evidence for wellness infusions.

Healthy agingMitochondrial healthCognition and brain
Related molecule
Not FDA approvedLimited or unclear evidenceOpen

Nicotinamide mononucleotide

An NAD+ precursor with small human trials and unresolved real-world clinical value.

Healthy agingMitochondrial healthMetabolic health
Related molecule
Not FDA approvedEarly human evidenceOpen

Nicotinamide riboside

An NAD+ precursor that reliably changes biomarkers but has not shown a consistent anti-aging or cognitive benefit.

Healthy agingMitochondrial healthCognition and brain
Related molecule
Not FDA approvedEarly human evidenceOpen

Oxytocin

A natural peptide hormone with approved obstetric products and unproven intranasal cognitive or social uses.

neuropsychiatric researchsocial cognitionreproductive health
Peptide
FDA approved for specific usesStrong human evidence for approved usesOpen

Pemvidutide

An investigational glucagon/GLP-1 dual agonist in mid-stage research for MASH, liver fat, and obesity.

dual receptor agonistliver researchweight research
Peptide
In clinical trialsEarly human evidenceOpen

Plecanatide

An FDA-approved gut-signaling peptide for chronic idiopathic constipation and IBS with constipation in adults.

digestive healthconstipationIBS
Peptide
FDA approved for specific usesStrong human evidence for approved usesOpen

Pramlintide

An FDA-approved amylin analog for selected insulin-treated diabetes patients, with unapproved weight-management research.

amylin analogdiabetesweight research
Peptide
FDA approved for specific usesStrong human evidence for approved usesOpen

Retatrutide

An investigational triple-receptor agonist in Phase 3 clinical trials.

GLP-1GIPglucagon
Peptide
In clinical trialsModerate human evidenceOpen

Rusfertide

An investigational hepcidin-mimetic peptide under FDA priority review for polycythemia vera.

hematologyiron regulationlate-stage research
Peptide
In clinical trialsModerate human evidenceOpen

Selank

An unapproved synthetic heptapeptide studied for anxiety, with a thin and uncertain human evidence base.

anxiety researchcognitive researchnootropic claims
Peptide
Not FDA approvedLimited or unclear evidenceOpen

Semaglutide

A GLP-1 medicine with FDA-approved products for type 2 diabetes and chronic weight management.

GLP-1metabolic healthapproved medicine
Peptide
FDA approved for specific usesStrong human evidence for approved usesOpen

Semax

An unapproved neuroactive heptapeptide with old, small human studies and substantial evidence gaps.

cognitive researchneuroprotectionnootropic claims
Peptide
Not FDA approvedLimited or unclear evidenceOpen

Sermorelin

A growth hormone-releasing hormone analog whose former FDA-approved product was discontinued.

growth hormone pathwaydiscontinued medicine
Peptide
DiscontinuedLimited or unclear evidenceOpen

Setmelanotide

An MC4-receptor peptide medicine approved for obesity caused by specific rare genetic conditions.

metabolic healthrare genetic obesitymelanocortin
Peptide
FDA approved for specific usesStrong human evidence for approved usesOpen

Sirolimus

An FDA-approved immunosuppressant with serious risks and unproven longevity use in healthy people.

Healthy agingImmune and infectionTransplant medicine
Related molecule
FDA approved for specific usesStrong human evidence for approved usesOpen

Spermidine

A food-derived polyamine linked to autophagy biology, with a negative phase 2 cognitive primary outcome.

Healthy agingCognition and brainCellular maintenance
Related molecule
Not FDA approvedEarly human evidenceOpen

Survodutide

An investigational glucagon/GLP-1 dual agonist in Phase 3 research for obesity and metabolic liver disease.

dual receptor agonistweight researchliver research
Peptide
In clinical trialsModerate human evidenceOpen

Taurine

A common nutrient-related molecule whose animal longevity story is challenged by newer human aging data.

Healthy agingMuscle and performanceHeart and vascular
Related molecule
Not FDA approvedLimited or unclear evidenceOpen

Teduglutide

An FDA-approved GLP-2 analog that improves intestinal absorption in short bowel syndrome dependent on parenteral support.

digestive healthintestinal failurerare disease
Peptide
FDA approved for specific usesStrong human evidence for approved usesOpen

Tesamorelin

A growth hormone-releasing factor analog approved for a narrow HIV-related indication.

growth hormone pathwaymetabolic healthapproved medicine
Peptide
FDA approved for specific usesStrong human evidence for approved usesOpen

Thymosin alpha-1

An immune-modulating peptide used in some countries but not FDA approved for any U.S. indication.

immune researchinfectious-disease researchcritical-care research
Peptide
Not FDA approvedModerate human evidenceOpen

Thymosin beta-4

A naturally occurring peptide studied in tissue repair; marketed fragments are not FDA approved.

recoverytissue repairexperimental
Peptide
Not FDA approvedMostly animal or lab researchOpen

Tirzepatide

A dual GIP/GLP-1 receptor agonist approved for specific metabolic and sleep-apnea uses.

GLP-1GIPmetabolic health
Peptide
FDA approved for specific usesStrong human evidence for approved usesOpen

Trofinetide

An FDA-approved synthetic peptide analog for Rett syndrome with modest trial benefits and frequent gastrointestinal adverse effects.

neurodevelopmentrare diseaseapproved medicine
Peptide
FDA approved for specific usesStrong human evidence for approved usesOpen

Urolithin A

A mitophagy-related metabolite with human biomarker and muscle-endurance signals but no approved disease use.

Mitochondrial healthMuscle and performanceHealthy aging
Related molecule
Not FDA approvedEarly human evidenceOpen

Vosoritide

A C-type natriuretic peptide analog approved to increase growth in children with achondroplasia.

bone growthrare diseasepediatric medicine
Peptide
FDA approved for specific usesStrong human evidence for approved usesOpen

Ziconotide

A cone-snail-inspired peptide medicine approved for severe chronic pain under specialist care.

pain researchneuroscienceapproved medicine
Peptide
FDA approved for specific usesStrong human evidence for approved usesOpen